Effects of a peer co-facilitated educational programme for parents of children with ADHD: a feasibility randomised controlled trial protocol

Ingunn Mundal, Rolf W Gråwe, Hege Hafstad, Carlos De Las Cuevas, Mariela Loreto Lara-Cabrera, Ingunn Mundal, Rolf W Gråwe, Hege Hafstad, Carlos De Las Cuevas, Mariela Loreto Lara-Cabrera

Abstract

Introduction: Significant numbers of children with attention deficit hyperactivity disorder (ADHD) display problems that cause multiple disabilities, deficits and handicaps that interfere with social relationships, development and school achievement. They may have multiple problems, which strain family dynamics and influence the child's treatment. Parent activation, described as parents' knowledge, skills and confidence in dealing with their child's health and healthcare, has been shown to be an important factor in improving health outcomes. Research suggests that parents need edification to learn skills crucial to the treatment and management of their children's healthcare. Promoting positive parenting techniques may reduce negative parenting factors in families. This study aims to assess the acceptability, feasibility and estimated sample size of a randomised controlled trial (RCT) comparing an ADHD peer co-led educational programme added to treatment as usual (TAU).

Methods and analysis: Using a randomised waitlist controlled trial, parents of children aged 6-12 years newly diagnosed with ADHD, and referred to a child mental health outpatient clinic in Mid-Norway, will receive TAU concomitant with a peer co-facilitated parental engagement educational programme (n=25). Parents in the control group will receive TAU, and the educational programme treatment within a waitlist period of 3-6 months (n=25). Parent activation, satisfaction, well-being, quality of life and treatment adherence, will be assessed at baseline (T0), 2 weeks (T1) pre-post intervention (T2, T3) and at 3 months follow-up (T4). Shared decision making, parents preferred role in health-related decisions and involvement, parent-reported symptoms of ADHD and child's overall level of functioning will be assessed at T0 and T4. Such data will be used to calculate the required sample size for a full-scale RCT.

Ethics and dissemination: Approval was obtained from the Regional Committee for Medicine and Health Research Ethics in Mid-Norway (ref: 2018/1196). The findings of this study are expected to provide valuable knowledge about how to optimise family education and management of ADHD and will be disseminated through presentations at conferences and publication in peer-reviewed journals.

Trial registration number: NCT04010851.

Keywords: child & adolescent psychiatry; developmental neurology & neurodisability; quality in health care.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Flow diagram illustrating recruitment and assessments of participants through the study. Adapted from SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials Consolidated.
Figure 2
Figure 2
Schedule for enrolment and measurements. Schedule for enrolment, interventions and measurements: Baseline (T0), 2 weeks (T1) pre–post intervention (T2, T3) and at 3-months follow-up (T4). Adapted from SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials Consolidated. BMQ, beliefs about medicines questionnaire; CGAS, children’s global assessment scale; CPS, control preferences scale; CSQ-3, client satisfaction questionnaire; MARS, medication adherence rating scale; MQLI, multicultural quality of life index; PAS, patient administrative system; PHBQ-P, health beliefs questionnaire on psychiatric treatment—parents version; P-PAM, parent patient activation measure; SDMQ, shared decision-making questionnaire; SNAP-IV, swanson, nolan and pelham questionnaire; WHO-5, WHO-5 well-being index.

References

    1. Storm M, Edwards A. Models of user involvement in the mental health context: intentions and implementation challenges. Psychiatr Q 2013;84:313–27. 10.1007/s11126-012-9247-x
    1. McMillan SS, Kendall E, Sav A, et al. . Patient-Centered approaches to health care: a systematic review of randomized controlled trials. Med Care Res Rev 2013;70:567–96. 10.1177/1077558713496318
    1. Doody O, Butler MP, Lyons R, et al. . Families’ experiences of involvement in care planning in mental health services: an integrative literature review. J Psychiatr Ment Health Nurs 2017;24:412–30. 10.1111/jpm.12369
    1. Lovdata Lov Om pasient- OG brukerrettigheter (pasient OG brukerrettighetsloven, 1999Helse- og omsorgsdepartementet; Available: [Accessed LOV-2020-06-19-79 fra 01.07.2020].
    1. Millar SL, Chambers M, Giles M. Service user involvement in mental health care: an evolutionary concept analysis. Health Expect 2016;19:209–21. 10.1111/hex.12353
    1. Melo EMdeOPde, Ferreira PL, Lima RAGde, Melo EM, Lima RA, et al. . The involvement of parents in the healthcare provided to hospitalzed children. Rev Lat Am Enfermagem 2014;22:432–9. 10.1590/0104-1169.3308.2434
    1. Ferrin M, Perez-Ayala V, El-Abd S, et al. . A randomized controlled trial evaluating the efficacy of a Psychoeducation program for families of children and adolescents with ADHD in the United Kingdom: results after a 6-month follow-up. J Atten Disord 2020;24:768–79. 10.1177/1087054715626509
    1. Wilens TE, Spencer TJ. Understanding attention-deficit/hyperactivity disorder from childhood to adulthood. Postgrad Med 2010;122:97–109. 10.3810/pgm.2010.09.2206
    1. Sayal K, Prasad V, Daley D, et al. . Adhd in children and young people: prevalence, care pathways, and service provision. Lancet Psychiatry 2018;5:175–86. 10.1016/S2215-0366(17)30167-0
    1. Mannuzza S, et al. Hyperactive boys almost grown up. Arch Gen Psychiatry 1991;48:77–83. 10.1001/archpsyc.1991.01810250079012
    1. Weiss M, Murray C. Assessment and management of attention-deficit hyperactivity disorder in adults. CMAJ 2003;168:715–22.
    1. Biederman J, Monuteaux MC, Mick E, et al. . Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med 2006;36:167–79. 10.1017/S0033291705006410
    1. Masi L, Gignac M. Adhd and comorbid disorders in childhood psychiatric problems, medical problems, learning disorders and developmental coordination disorder. Clin Psychiatry 2015;1 10.21767/2471-9854.100005
    1. Ferrin M, Taylor E. Child and caregiver issues in the treatment of attention deficit–hyperactivity disorder: education, adherence and treatment choice. Future Neurol 2011;6:399–413. 10.2217/fnl.11.5
    1. Wesseldijk LW, Dieleman GC, van Steensel FJA, et al. . Risk factors for parental psychopathology: a study in families with children or adolescents with psychopathology. Eur Child Adolesc Psychiatry 2018;27:1575–84. 10.1007/s00787-018-1156-6
    1. Egger HL, Angold A. Common emotional and behavioral disorders in preschool children: presentation, nosology, and epidemiology. J Child Psychol Psychiatry 2006;47:313–37. 10.1111/j.1469-7610.2006.01618.x
    1. Al Ansari A, Hamadeh RR, Jahrami H, et al. . Outcomes of children with attention deficit/hyperactivity disorder: global functioning and symptoms persistence. East Mediterr Health J 2017;23:589–93. 10.26719/2017.23.9.589
    1. Fairchild G, van Goozen SHM, Calder AJ, et al. . Research review: evaluating and reformulating the developmental taxonomic theory of antisocial behaviour. J Child Psychol Psychiatry 2013;54:924–40. 10.1111/jcpp.12102
    1. Dahl V, Ramakrishnan A, Spears AP, et al. . Psychoeducation interventions for parents and teachers of children and adolescents with ADHD: a systematic review of the literature. J Dev Phys Disabil 2020;32:257–92. 10.1007/s10882-019-09691-3
    1. Rueger SY, Katz RL, Risser HJ, et al. . Relations between parental affect and parenting behaviors: a meta-analytic review. Parenting 2011;11:1–33. 10.1080/15295192.2011.539503
    1. Montoya A, Colom F, Ferrin M. Is psychoeducation for parents and teachers of children and adolescents with ADHD efficacious? A systematic literature review. Eur Psychiatry 2011;26:166–75. 10.1016/j.eurpsy.2010.10.005
    1. Ferrin M, Moreno-Granados JM, Salcedo-Marin MD, et al. . Evaluation of a psychoeducation programme for parents of children and adolescents with ADHD: immediate and long-term effects using a blind randomized controlled trial. Eur Child Adolesc Psychiatry 2014;23:637–47. 10.1007/s00787-013-0494-7
    1. Lopez MA, Toprac MG, Crismon ML, et al. . A psychoeducational program for children with ADHD or depression and their families: results from the CMAP feasibility study. Community Ment Health J 2005;41:51–66. 10.1007/s10597-005-2599-z
    1. Miranda A, Presentación MJ, Soriano M. Effectiveness of a school-based multicomponent program for the treatment of children with ADHD. J Learn Disabil 2002;35:547–63. 10.1177/00222194020350060601
    1. Monastra VJ. Overcoming the barriers to effective treatment for attention-deficit/hyperactivity disorder: a neuro-educational approach. Int J Psychophysiol 2005;58:71–80. 10.1016/j.ijpsycho.2005.03.010
    1. Svanborg P, Thernlund G, Gustafsson PA, et al. . Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naïve Swedish children and adolescents. Eur Child Adolesc Psychiatry 2009;18:240–9. 10.1007/s00787-008-0725-5
    1. Corkum P, Rimer P, Schachar R. Parental knowledge of attention-deficit hyperactivity disorder and opinions of treatment options: impact on enrollment and adherence to a 12-month treatment trial. Can J Psychiatry 1999;44:1043–8. 10.1177/070674379904401011
    1. Hack S, Chow B. Pediatric psychotropic medication compliance: a literature review and research-based suggestions for improving treatment compliance. J Child Adolesc Psychopharmacol 2001;11:59–67. 10.1089/104454601750143465
    1. Mirza M, Krischer A, Stolley M, et al. . Review of parental activation interventions for parents of children with special health care needs. Child Care Health Dev 2018;44:401–26. 10.1111/cch.12554
    1. Roughan LA, Parker JR, Mercer L. Improving interventions for parents of children and young people with autism spectrum disorder (ASD) in CAMHS. BMJ Open Qual 2019;8:e000261. 10.1136/bmjoq-2017-000261
    1. Kieckhefer GM, Trahms CM, Churchill SS, et al. . A randomized clinical trial of the building on family strengths program: an education program for parents of children with chronic health conditions. Matern Child Health J 2014;18:563–74. 10.1007/s10995-013-1273-2
    1. van Gestel-Timmermans H, Brouwers EPM, van Assen MALM, et al. . Effects of a peer-run course on recovery from serious mental illness: a randomized controlled trial. Psychiatr Serv 2012;63:54–60. 10.1176/appi.ps.201000450
    1. Turner A, Anderson JK, Wallace LM, et al. . An evaluation of a self-management program for patients with long-term conditions. Patient Educ Couns 2015;98:213–9. 10.1016/j.pec.2014.08.022
    1. Sharma S, Wallace LM, Kosmala-Anderson J, et al. . A process evaluation using a self determination theory measure of the co-delivery of self management training by clinicians and by lay tutors. Patient Educ Couns 2013;90:38–45. 10.1016/j.pec.2012.09.002
    1. Elg M, Engström J, Witell L, et al. . Co‐creation and learning in health‐care service development. J Service Management 2012;23:328–43. 10.1108/09564231211248435
    1. Stenberg U, Haaland-Øverby M, Fredriksen K, et al. . A scoping review of the literature on benefits and challenges of participating in patient education programs aimed at promoting self-management for people living with chronic illness. Patient Educ Couns 2016;99:1759–71. 10.1016/j.pec.2016.07.027
    1. Lara-Cabrera ML, Gjerden M, Gråwe RW, et al. . Short-term effects of a peer co-led educational programme delivered before mental health treatment: a randomised controlled trial. Patient Educ Couns 2016;99:1257–61. 10.1016/j.pec.2016.02.006
    1. Lara-Cabrera ML, Salvesen Øyvind, Nesset MB, et al. . The effect of a brief educational programme added to mental health treatment to improve patient activation: a randomized controlled trial in community mental health centres. Patient Educ Couns 2016;99:760–8. 10.1016/j.pec.2015.11.028
    1. Chacko A, Hopkins K, Acri M, et al. . Expanding attention-deficit/hyperactivity disorder service provision in urban socioeconomically disadvantaged communities: a pilot study. Clin Pract Pediatr Psychol 2020;8:189–94. 10.1037/cpp0000321
    1. Chacko A, Scavenius C. Bending the curve: a community-based behavioral parent training model to address ADHD-Related concerns in the voluntary sector in Denmark. J Abnorm Child Psychol 2018;46:505–17. 10.1007/s10802-017-0310-9
    1. Stenberg U, Haaland-Øverby M, Koricho AT, et al. . How can we support children, adolescents and young adults in managing chronic health challenges? A scoping review on the effects of patient education interventions. Health Expect 2019;22:849–62. 10.1111/hex.12906
    1. Edwards AG, Brebner CM, McCormack PF, et al. . From 'parent' to 'expert': how parents of children with autism spectrum disorder make decisions about which intervention approaches to access. J Autism Dev Disord 2018;48:2122–38. 10.1007/s10803-018-3473-5
    1. Chesterfield JA, Porzig-Drummond R, Stevenson RJ, et al. . Evaluating a brief behavioral parenting program for parents of school-aged children with ADHD. Parenting 2020:1–25. 10.1080/15295192.2020.1777783
    1. Daley D, Van Der Oord S, Ferrin M, et al. . Practitioner review: current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder. J Child Psychol Psychiatry 2018;59:932–47. 10.1111/jcpp.12825
    1. Sonuga-Barke EJS, Barton J, Daley D, et al. . A comparison of the clinical effectiveness and cost of specialised individually delivered parent training for preschool attention-deficit/hyperactivity disorder and a generic, group-based programme: a multi-centre, randomised controlled trial of the new forest parenting programme versus Incredible years. Eur Child Adolesc Psychiatry 2018;27:797–809. 10.1007/s00787-017-1054-3
    1. Bell ML, Whitehead AL, Julious SA. Guidance for using pilot studies to inform the design of intervention trials with continuous outcomes. Clin Epidemiol 2018;10:153–7. 10.2147/CLEP.S146397
    1. Julious SA. Pilot studies in clinical research. Stat Methods Med Res 2016;25:995–6. 10.1177/0962280216651022
    1. Whitehead AL, Julious SA, Cooper CL, et al. . Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res 2016;25:1057–73. 10.1177/0962280215588241
    1. Chan A-W, Tetzlaff JM, Gøtzsche PC, et al. . Spirit 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:e7586. 10.1136/bmj.e7586
    1. Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet 2002;359:614–8. 10.1016/S0140-6736(02)07750-4
    1. Chan A-W, Tetzlaff JM, Altman DG, et al. . Spirit 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200–7. 10.7326/0003-4819-158-3-201302050-00583
    1. DeCamp LR, Leifheit K, Shah H, et al. . Cross-Cultural validation of the parent-patient activation measure in low income Spanish- and English-speaking parents. Patient Educ Couns 2016;99:2055–62. 10.1016/j.pec.2016.07.003
    1. Fowles JB, Terry P, Xi M, et al. . Measuring self-management of patients' and employees' health: further validation of the patient activation measure (PAM) based on its relation to employee characteristics. Patient Educ Couns 2009;77:116–22. 10.1016/j.pec.2009.02.018
    1. Hibbard JH, Mahoney ER, Stock R, et al. . Do increases in patient activation result in improved self-management behaviors? Health Serv Res 2007;42:1443–63. 10.1111/j.1475-6773.2006.00669.x
    1. Attkisson CC, Zwick R. The client satisfaction questionnaire. psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann 1982;5:233–7. 10.1016/0149-7189(82)90074-x
    1. Bech P, Olsen LR, Kjoller M, et al. . Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 mental health subscale and the WHO-Five well-being scale. Int J Methods Psychiatr Res 2003;12:85–91. 10.1002/mpr.145
    1. Mezzich JE, Cohen NL, Ruiperez MA, et al. . The multicultural quality of life index: presentation and validation. J Eval Clin Pract 2011;17:357–64. 10.1111/j.1365-2753.2010.01609.x
    1. De las Cuevas C, Rivero-Santana A, Perestelo-Perez L, et al. . Adaptation and validation study of the beliefs about medicines questionnaire in psychiatric outpatients in a community mental health setting. Hum Psychopharmacol 2011;26:140–6. 10.1002/hup.1185
    1. Jónsdóttir H, Friis S, Horne R, et al. . Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders. Acta Psychiatr Scand 2009;119:78–84. 10.1111/j.1600-0447.2008.01279.x
    1. Horne R, Chapman SCE, Parham R, et al. . Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns framework. PLoS One 2013;8:e80633. 10.1371/journal.pone.0080633
    1. De Las Cuevas C, de Leon J. Development and validation of the patient's health belief questionnaire on psychiatric treatment. Patient Prefer Adherence 2019;13:527–36. 10.2147/PPA.S201144
    1. Morán-Sánchez I, Gómez-Vallés P, Bernal-López María Ángeles, et al. . Shared decision-making in outpatients with mental disorders: Patients’ preferences and associated factors. J Eval Clin Pract 2019;25:1200–9. 10.1111/jep.13246
    1. Degner LF, Sloan JA, Venkatesh P. The control preferences scale. Can J Nurs Res 1997;29:21–43.
    1. Barr PJ, Thompson R, Walsh T, et al. . The psychometric properties of collaborate: a fast and frugal patient-reported measure of the shared decision-making process. J Med Internet Res 2014;16:e2. 10.2196/jmir.3085
    1. Swanson JM, Kraemer HC, Hinshaw SP, et al. . Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and odd symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 2001;40:168–79. 10.1097/00004583-200102000-00011
    1. Kornør H, Bøe T. Måleegenskaper ved den norske versjonen av swanson, nolan og pelham vurderingsskala for lærere og foreldre - versjon IV (SNAP-IV). PsykTestBarn 2011;1:1.
    1. Lundh A, Kowalski J, Sundberg CJ, et al. . Children's global assessment scale (CGAS) in a naturalistic clinical setting: inter-rater reliability and comparison with expert ratings. Psychiatry Res 2010;177:206–10. 10.1016/j.psychres.2010.02.006
    1. Shaffer D, Gould MS, Brasic J, et al. . A children's global assessment scale (CGAS). Arch Gen Psychiatry 1983;40:1228–31. 10.1001/archpsyc.1983.01790100074010
    1. Schorre BEH, Vandvik IH. Global assessment of psychosocial functioning in child and adolescent psychiatry. A review of three unidimensional scales (CGAS, GAF, GAPD). Eur Child Adolesc Psychiatry 2004;13:273–86. 10.1007/s00787-004-0390-2

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner